Neoadjuvant chemoradiation therapy with capecitabine (CAP) plus oxaliplatin (OX) in rectal cancer: Final results of a phase II study

被引：1

作者：

Carlomagno, C. ^{[1
]}

D'Armiento, F. ^{[1
]}

Farella, A. ^{[1
]}

Cannella, L. ^{[1
]}

De Stefano, A. ^{[1
]}

Colantuoni, M. ^{[1
]}

Alfieri, S. ^{[1
]}

Marra, M. ^{[1
]}

Totaro, G. ^{[1
]}

Pepe, S. ^{[1
]}

机构：

[1] Univ Naples Federico II, Naples, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.4090

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4090

引用

页数：1

共 50 条

[41] Effect of neoadjuvant cetuximab, capecitabine, and radiotherapy for locally advanced rectal cancer: results of a phase II study
Sun, Pei-Long
Li, Bing
Ye, Qi-Fa
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (10) : 1325 - 1332
[42] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
Giampietro Gasparini
Francesco Torino
Takayuki Ueno
Stefano Cascinu
Teresa Troiani
Alberto Ballestrero
Rossana Berardi
Junichi Shishido
Akihiko Yoshizawa
Yukiko Mori
Satoshi Nagayama
Paola Morosini
Masakazu Toi
Angiogenesis, 2012, 15 : 141 - 150
[43] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
Gasparini, Giampietro
Torino, Francesco
Ueno, Takayuki
Cascinu, Stefano
Troiani, Teresa
Ballestrero, Alberto
Berardi, Rossana
Shishido, Junichi
Yoshizawa, Akihiko
Mori, Yukiko
Nagayama, Satoshi
Morosini, Paola
Toi, Masakazu
ANGIOGENESIS, 2012, 15 (01) : 141 - 150
[44] A phase II study of resection followed by capecitabine plus oxaliplatin for liver metastasis of colorectal cancer (REX study): Final analysis
Tamagawa, H.
Sugimoto, N.
Watanabe, T.
Satake, H.
Kataoka, K.
Kamei, K.
Kobayashi, M.
Munakata, K.
Fukunaga, M.
Kotaka, M.
Satoh, T.
Kanazawa, A.
Kurata, T.
Tomita, N.
ANNALS OF ONCOLOGY, 2022, 33 : S275 - S275
[45] The results of neoadjuvant chemoradiation therapy in combined treatment of rectal cancer
Abdujapparov, A.
Ten, Y.
Korakhadjaev, B.
EUROPEAN JOURNAL OF CANCER, 2017, 72 : S50 - S50
[46] The results of neoadjuvant chemoradiation therapy in combined treatment of rectal cancer
Abdujapparov, A. S.
Ten, Y. V.
Korakhadjaev, B. S.
ANNALS OF ONCOLOGY, 2016, 27
[47] Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer
Lee, Eun Mi
Hong, Yong Sang
Kim, Kyu-pyo
Lee, Jae-Lyun
Kim, Sun Young
Park, Young Suk
Choi, Doo Ho
Kim, Jong Hoon
Lim, Seok-Byung
Yu, Chang Sik
Kim, Jin Cheon
Lee, Ju Hee
Kim, Ah Young
Kim, Tae Won
CANCER SCIENCE, 2013, 104 (01) : 111 - 115
[48] Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer
Rödel, C
Grabenbauer, GG
Papadopoulos, T
Hohenberger, W
Schmoll, HJ
Sauer, R
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3098 - 3104
[49] Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer.
Allegra, Carmen Joseph
Yothers, Greg
O'Connell, Michael J.
Roh, Mark S.
Lopa, Samia H.
Petrelli, Nicholas J.
Beart, Robert W.
Sharif, Saima
Wolmark, Norman
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[50] A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study final results.
Tamberi, Stefano
Grassi, Elisa
Zingaretti, Chiara
Papiani, Giorgio
Pini, Sara
Corbelli, Jody
Di Bartolomeo, Maria
Pietrantonio, Filippo
Frassineti, Giovanni Luca
Passardi, Alessandro
Gelsomino, Fabio
Marzola, Marina
Banzi, Maria
Bonetti, Andrea Vincent
Petracci, Elisabetta
Moretti, Chiara Carli
Banchelli, Isabella
Tassinari, Davide
Ugolini, Giampaolo
Nanni, Oriana
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17)

← 1 2 3 4 5 →